The success of regorafenib in hepatocellular carcinoma in a world of failures. Learnings for future developments

Saved in:
Bibliographic Details
Published inOncotarget Vol. 8; no. 63; pp. 106151 - 106152
Main Authors Reig, Maria, Díaz-González, Álvaro, Bruix, Jordi
Format Journal Article
LanguageEnglish
Published United States Impact Journals LLC 05.12.2017
Subjects
sorafenib
systemic treatment
trial design
new drugs
hepatocellular carcinoma
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Editorial-2
ObjectType-Commentary-1
ISSN:1949-2553
1949-2553
DOI:10.18632/oncotarget.22382